Newborn guidance emphasizes preparation, team training, and extended delayed cord clamping. The guidelines include new and revised recommendations across pediatric basic and advanced life support and ...
Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies. The prospective, randomized, ...
Indication expansions include hidradenitis suppurativa for patients 12 years and up, as well as for patients with uveitis aged 2 years and older. FDA approval extends adalimumab-aaty’s indications to ...
Post-pandemic middle schoolers gained sexual health knowledge but showed fewer positive belief changes, study finds. The COVID-19 pandemic disrupted multiple facets of education, including how middle ...
Results suggest that a single, brief exposure to general anesthesia for surgery is unlikely to impair short-term neurodevelopment in young children. Preliminary results from a randomized clinical ...
New evidence-based guideline provides 22 recommendations to standardize nutritional care for neonates after enterostomy. Although neonatal nutrition guidelines exist, none have previously focused on ...
The indication approved is for children aged 6 years and older who weigh at least 45 kg (99 lbs) for the preventive treatment of episodic migraine. On August 5, 2025, the FDA approved ...
New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year. Vaccination coverage among kindergartners in the United States declined ...
An expert discusses practical strategies for assessing atopic dermatitis severity, highlighting simple yet effective tools such as the Investigator Global Assessment (IGA) scale, palm-based body ...
A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies. An international team of researchers ...
The American Academy of Pediatrics warns families to avoid home fireworks and offers safer alternatives to prevent injuries, especially in young children. Each year, thousands of children, teens, and ...
Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...